Rabbivac–B
Attenuated vaccine against rabbit myxomatosis
The vaccine is intended for the prevention of rabbit myxomatosis in a safe zone, as well as in threatened and dysfunctional farms.
The vaccine provides the formation of an immune response in rabbits to myxomatosis 5-9 days after a single application of 12 months.
injectable suspension for pigs
injectable suspension for swin
INGELVAC PRRSFLEX EU 50ml
injectable suspension for pigs
Vaccine against rabbit hemorrhagic disease